Central nervous targets for the treatment of bladder dysfunction. - Wikidata - awgldk - TriplyDB

Central nervous targets for the treatment of bladder dysfunction.

Central nervous targets for the treatment of bladder dysfunction.

http://www.wikidata.org/entity/Q38119899

about

Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.Iatrogenic nocturnal eneuresis – an overlooked side effect of anti histamines?Analysis of the Prevalence and Factors Associated with Nocturia in Adult Korean Men.Presence of multiple peripheral circadian oscillators in the tissues controlling voiding function in mice.New horizons: urinary incontinence in older people.Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS).ICI-RS 2015-Is a better understanding of sleep the key in managing nocturia?Non-motor features of Parkinson disease.Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson's Disease.Influence of urethane-anesthesia on the effect of resiniferatoxin treatment on bladder function in rats with spinal cord injury.Sleep fragmentation and periodic limb movements in children with monosymptomatic nocturnal enuresis and polyuria.Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients.

P2860

Q33870858-2AC6F1B7-8804-4590-AA56-9370984D63F5 Q37091249-CF269523-217F-45A1-AF8B-0C6CC7B886B4 Q37615140-8A523BD4-5526-4AB7-A166-0D57A5E5A3E8 Q37679428-86935106-F79D-4EF6-8C2D-78866B20064D Q38186569-9C298CF0-8298-45C0-AB7E-075CB7399DA5 Q38624933-2DF965E6-0513-49E8-B1B8-FB44DC714BCC Q38819003-89AAD2EC-EFB1-4602-B080-152E0B6BA5AE Q39358549-107623C0-36E0-4D41-AF95-D5145CFE5212 Q41387301-6A19F566-4EA7-4C29-80DA-788EE4E5BEEA Q47930688-D36F0303-789B-4FD3-89C6-79F846A8D1D4 Q47994970-C1022C4C-01A6-4DFD-A827-28F7D3C66070 Q53691599-76CE1962-0C66-4CDB-869B-E538B857A789

P2860

Central nervous targets for the treatment of bladder dysfunction.

http://www.wikidata.org/entity/Q38119899

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Central nervous targets for the treatment of bladder dysfunction.

@en

type

label

Central nervous targets for the treatment of bladder dysfunction.

@en

prefLabel

Central nervous targets for the treatment of bladder dysfunction.

@en

P1433

Q38119899-C01CFF3E-D3A0-464E-8E7C-D86CCA2BC31F

P1476

Q38119899-403772DD-A67A-4EF7-AF59-29D5213A4FF6

P2093

Q38119899-647D022C-DC4D-4242-9060-2044EF8736CC

Q38119899-84CBFFFA-0C27-4A28-85D0-A23E1B3E67BC

Q38119899-B6A4CD8A-2E82-4736-9AAB-FF3ABC0D401C

Q38119899-E9D717DE-5E14-4BEE-B4C8-AD276A717821

P2860

Q38119899-05286852-FCFB-4AC6-BE53-34E37F8C95AE

Q38119899-064A2BEC-A851-4320-A144-22B71A0FFFB7

Q38119899-081082EB-73BA-4388-85C1-AFA34204CC71

Q38119899-2060CA91-52DB-4574-8987-6D9CFE6B5CDF

Q38119899-234D6A18-FBD0-493C-BEFC-4C6787A3E011

Q38119899-23FBEF22-D314-4837-8AB9-87372A75B8FD

Q38119899-2F47FCCB-0BBD-4EEA-858A-B3BCDD6EAAF3

Q38119899-2F743BF0-0C21-4EB0-93B9-65A60278CF3B

Q38119899-302257D7-AF08-4ECD-AE52-3BDD98C97D6C

Q38119899-323D2495-0140-4E6A-A2AC-AFB34129715F

P304

Q38119899-39F2B0FE-975F-49D1-99A4-535A16883DBA

P31

Q38119899-1A2CAD76-9D07-4E3E-A24B-94B13E23CD37

P356

Q38119899-B967E17B-9F75-4708-AA3F-1872DFB90D7E

P433

Q38119899-CAE0DB2A-F67F-4C41-AD0B-DB8A9AF57827

P478

Q38119899-71F364A0-A42C-4DB2-B0A2-56382C19F840

P577

Q38119899-F4D641A7-A77F-42E5-9C3D-FF7183F53F57

P5875

Q38119899-CC824F4A-FC66-4591-8164-ADAE912A2C0D

P698

Q38119899-4D198C40-20B1-4DF1-BF4F-A837252E5F6B

P356

P1433

Neurourology and Urodynamics

P1476

Central nervous targets for the treatment of bladder dysfunction.

@en

P2093

Minoru Miyazato

http://www.w3.org/2001/XMLSchema#string

Naoki Yoshimura

http://www.w3.org/2001/XMLSchema#string

Satoru Yoshikawa

http://www.w3.org/2001/XMLSchema#string

Takeya Kitta

http://www.w3.org/2001/XMLSchema#string

P2860

The neural control of micturition

New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists

Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy

Voiding dysfunction in patients with spastic paraplegia: urodynamic evaluation and response to continuous intrathecal baclofen.

Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats.

The bladder cooling reflex and the use of cooling as stimulus to the lower urinary tract.

Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin

Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats

Neural control of the lower urinary tract: peripheral and spinal mechanisms

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

P304

59-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NAU.22455

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247157815

http://www.w3.org/2001/XMLSchema#string

P698

23832777

http://www.w3.org/2001/XMLSchema#string